Here begins the text.

The 5th Subcommittee on Microbiome

Press Release

When clicking with the mouse or pressing the tab key, Press Release is displayed.

Wednesday, May 12, 2021   14:00-15:40
* Given the impact of COVID-19, the conference was held online.

Agenda / List of Handouts

  1. Lecture on Microbiome Research and Discussion
    • Current Status and Future Prospects of Live Biotherapeutic Products (LBPs) Attracting Attention As New Therapeutic Modalities
        NAKAMURA Mitsuaki, Senior Director, Bio Palette Co., Ltd. (Lecture and Discussion)
        TAMIYA Taiga, Research and Development Manager, Bio Palette Co., Ltd. (Discussion)
  2. Prewriting the Assigned Parts to Members
  3. Others

List of Handouts

Confidentiality Classification of Handouts

Document 1

Lecture Material by Bio Palette Co., Ltd.
Document 2   Draft Report on Microbiome (Manufacturing Quality; Chapter 2 & 4)
Document 3   Draft Report (Non-clinical Trials)
Document 4   Draft Report (Integrated Version)

Reference Document 1

Member List of the Subcommittee on Microbiome
Reference Document 2   Genetical Recombination

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.

000048450
0
The 5th Subcommittee on Microbiome
/english/rs-sb-std/sb/subcommittees/0014.html
en